Michelle Pedersen

Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma

Han Chong Toh, Pei‐Jer Chen, Brian I. Carr et al. · Cancer · 2012 · 106 citations · Full text

A phase 1 study of ABT-806 in subjects with advanced solid tumors

James M. Cleary, David A. Reardon, Nilofer S. Azad et al. · Investigational New Drugs · 2015 · 37 citations

Malignant Disease, Medicine, Pathology +6

A phase 1 study evaluating ABT-414 in combination with temozolomide (TMZ) for subjects with recurrent or unresectable glioblastoma (GBM).

Hui Gan, Lisa Fichtel, Andrew B. Lassman et al. · Journal of Clinical Oncology · 2014 · 22 citations

Pathology, Immunotherapeutics, High-grade Gliomas +18

Phase I study of ABT-414 mono- or combination therapy with temozolomide (TMZ) in recurrent glioblastoma (GBM).

Hui Gan, Kyriakos P. Papadopoulos, Lisa Fichtel et al. · Journal of Clinical Oncology · 2015 · 20 citations

Immunology, Pharmacotherapy, Immunotherapeutics +18

A phase I and biodistribution study of ABT-806i, an ¹¹¹indium-labeled conjugate of the tumor-specific anti-EGFR antibody ABT-806.

Hui Gan, Matthew Burge, Benjamin Solomon et al. · Journal of Clinical Oncology · 2013 · 17 citations

Immunology, Pathology, Skin Pt +20